Ibnsina Pharma reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was EGP 5,628.78 million compared to EGP 4,828.51 million a year ago. Net income was EGP 137.2 million compared to EGP 111.63 million a year ago. Basic earnings per share from continuing operations was EGP 0.1029 compared to EGP 0.0857 a year ago.
For the nine months, sales was EGP 15,752.3 million compared to EGP 13,701.76 million a year ago. Net income was EGP 242.19 million compared to EGP 200.62 million a year ago. Basic earnings per share from continuing operations was EGP 0.18 compared to EGP 0.1457 a year ago.